Concepts (62)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Diabetes Mellitus, Type 2 | 8 | 2023 | 1273 | 1.200 |
Why?
|
| Weight Loss | 2 | 2020 | 481 | 0.540 |
Why?
|
| Hypoglycemic Agents | 5 | 2023 | 443 | 0.520 |
Why?
|
| Blood Glucose | 5 | 2023 | 1133 | 0.430 |
Why?
|
| Insulin | 4 | 2023 | 1203 | 0.400 |
Why?
|
| Metformin | 3 | 2020 | 150 | 0.270 |
Why?
|
| Blood Glucose Self-Monitoring | 2 | 2023 | 122 | 0.230 |
Why?
|
| Neuraminidase | 1 | 2025 | 36 | 0.230 |
Why?
|
| Orthomyxoviridae Infections | 1 | 2025 | 59 | 0.230 |
Why?
|
| Cigarette Smoking | 1 | 2025 | 59 | 0.220 |
Why?
|
| Influenza A virus | 1 | 2025 | 138 | 0.220 |
Why?
|
| Standard of Care | 1 | 2023 | 130 | 0.200 |
Why?
|
| Cross-Over Studies | 1 | 2023 | 317 | 0.190 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2025 | 770 | 0.190 |
Why?
|
| Patient Compliance | 3 | 2020 | 470 | 0.180 |
Why?
|
| Los Angeles | 1 | 2020 | 16 | 0.180 |
Why?
|
| Adolescent | 8 | 2023 | 19412 | 0.170 |
Why?
|
| Biomarkers, Pharmacological | 1 | 2019 | 10 | 0.160 |
Why?
|
| Pilot Projects | 1 | 2023 | 1395 | 0.150 |
Why?
|
| Influenza, Human | 1 | 2025 | 662 | 0.150 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 1 | 2025 | 604 | 0.150 |
Why?
|
| Odds Ratio | 1 | 2020 | 1252 | 0.140 |
Why?
|
| Body Mass Index | 2 | 2020 | 1563 | 0.130 |
Why?
|
| Lost to Follow-Up | 1 | 2015 | 33 | 0.120 |
Why?
|
| Medication Adherence | 1 | 2020 | 397 | 0.120 |
Why?
|
| Child | 7 | 2022 | 24609 | 0.100 |
Why?
|
| Longitudinal Studies | 1 | 2015 | 1320 | 0.090 |
Why?
|
| Biomarkers | 1 | 2020 | 3105 | 0.090 |
Why?
|
| Risk Factors | 2 | 2022 | 10278 | 0.080 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2015 | 847 | 0.080 |
Why?
|
| Humans | 9 | 2025 | 125025 | 0.070 |
Why?
|
| Sialic Acid Binding Immunoglobulin-like Lectins | 1 | 2025 | 9 | 0.060 |
Why?
|
| Male | 6 | 2020 | 61429 | 0.060 |
Why?
|
| Macrophages, Alveolar | 1 | 2025 | 49 | 0.060 |
Why?
|
| Smoke | 1 | 2025 | 61 | 0.060 |
Why?
|
| Female | 6 | 2020 | 66669 | 0.060 |
Why?
|
| Prognosis | 2 | 2020 | 4683 | 0.040 |
Why?
|
| Insulin Glargine | 1 | 2019 | 7 | 0.040 |
Why?
|
| Adiponectin | 1 | 2019 | 113 | 0.040 |
Why?
|
| Treatment Failure | 1 | 2019 | 335 | 0.040 |
Why?
|
| Risk Reduction Behavior | 1 | 2019 | 145 | 0.040 |
Why?
|
| Administration, Oral | 1 | 2020 | 683 | 0.040 |
Why?
|
| Self Care | 1 | 2019 | 212 | 0.030 |
Why?
|
| Age of Onset | 1 | 2019 | 600 | 0.030 |
Why?
|
| Lung | 1 | 2025 | 1490 | 0.030 |
Why?
|
| Poverty Areas | 1 | 2015 | 32 | 0.030 |
Why?
|
| Mice, Inbred C57BL | 1 | 2025 | 4415 | 0.030 |
Why?
|
| Drug Therapy, Combination | 1 | 2019 | 1158 | 0.030 |
Why?
|
| Incidence | 1 | 2022 | 3130 | 0.030 |
Why?
|
| Pandemics | 1 | 2022 | 1112 | 0.030 |
Why?
|
| Insulin Resistance | 1 | 2019 | 641 | 0.030 |
Why?
|
| Disease Models, Animal | 1 | 2025 | 4405 | 0.030 |
Why?
|
| Treatment Outcome | 2 | 2019 | 12269 | 0.030 |
Why?
|
| Clinical Trials as Topic | 1 | 2015 | 1095 | 0.020 |
Why?
|
| Random Allocation | 1 | 2012 | 438 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2020 | 5167 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2020 | 4819 | 0.020 |
Why?
|
| Weight Gain | 1 | 2012 | 400 | 0.020 |
Why?
|
| Young Adult | 1 | 2022 | 9054 | 0.020 |
Why?
|
| Mice | 1 | 2025 | 17711 | 0.020 |
Why?
|
| Surveys and Questionnaires | 1 | 2015 | 3674 | 0.020 |
Why?
|
| Animals | 1 | 2025 | 34205 | 0.010 |
Why?
|